• Merck and Schering-Plough filed a new drug application for Zetia with the FDA in December 2001.

    FORBES: Schering-Plough And Merck's New Hope

  • The gamble paid off, as Merck was able to file a new-drug application six weeks before Novartis.

    FORBES: Health

  • All signals point to this being one of the best times to submit a new drug application in years.

    FORBES: Why Presidents Don't Shape The FDA

  • After completion of more pre-clinical studies, Short hopes to file Diversa's first investigational new drug application sometime next year.

    FORBES: Taking Aim At Anthrax

  • But rejections, because they are not final and are therefore part of communication during an ongoing drug application, are considered confidential.

    FORBES: Why FDA Communications Must Be Public

  • The New Drug Application for this drug was filed in 2005, and approval, which was not certain, took over 5 years.

    FORBES: Do Get-Rich-Quick Biotech Investors Know How to Read?

  • On the horizon, Novartis just submitted a new drug application for an arthritis drug, Prexige, to the U.S. Food and Drug Administration.

    FORBES: Novartis CEO Plays Waiting Game

  • The new drug application for dalbavancin should be submitted by year's end.

    FORBES: Building A Better Bacteria Killer

  • Onyx and Bayer filed their new drug application first, but that left analysts and investors guessing as to when Pfizer would file its new drug application.

    FORBES: Pfizer Plays A Guessing Game

  • In fact, a supergeneric will sometimes need a completely new drug application in order to gain approval from the Food and Drug Administration (FDA).

    FORBES: Magazine Article

  • In 1994, Marion Merrill Dow, now part of Sanofi-Aventis, filed a new drug application for the drug as a treatment for all kinds of epilepsy.

    FORBES: Magazine Article

  • The FDA had initially declined to approve Zioptan, sending Merck a "complete response" letter in November asking for more information about the new drug application.

    WSJ: New Drug Approved to Treat Eye Condition

  • InterMune announced that the FDA has posted briefing documents for the March 9 Pulmonary-Allergy Drugs Advisory Committee meeting to review their New Drug Application for pirfenidone.

    FORBES: Magazine Article

  • Monday Takeda said the FDA recommended it suspend top doses of TAK-475, and said the agency wants additional clinical data before Takeda submits a new drug application.

    FORBES: The Heart Drug Junkyard

  • The company also has improved drug application methods, such as a foaming mousse in its Desilux and Primolux drugs to add a moisturizing benefit to irritated skin.

    FORBES

  • Sanofi-Aventis ( SNY - news - people ), filed a new drug application for the drug as a treatment for all kinds of epilepsy.

    FORBES: Health Care

  • The FDA had never closed the file on the drug, and in December 2007, Shields' data formed the basis of a new drug application for infantile spasms.

    FORBES: Health Care

  • The FDA is currently considering a new drug application for Zetia, a cholesterol medicine Schering is developing with Merck (nyse: MRK - news - people ).

    FORBES: Magazine Article

  • Pfizer also said this morning that the Food and Drug Administration refused to accept a new drug application for an experimental medicine the company got from its acquisition of FoldRx.

    FORBES: Pfizer's Capsugel Sale Could Set Stage For Other Divestitures

  • The act created deadlines, six months or a year after a drug application is filed, by which the FDA's decisions must be made, and the agency is meeting those targets.

    FORBES: Blindsided

  • Vivus resubmitted its new drug application for Qnexa in October with a contraindication for women of childbearing age, and is studying the impact of the drug in pregnant women and babies.

    FORBES: Vivus Data Shows Weight Loss Drug Ingredient Associated with Oral Clefts

  • Some key background: In May 2003, Paddock filed an Abbreviated New Drug Application (ANDA) with FDA for approval of a generic version of AndroGel, as did another generic producer, Watson Pharmaceutical.

    FORBES: FTC Orders Merged Drug Companies Not to Do "Pay-for-Delay" Settlements

  • Today's announcement will likely give investors more confidence that the drug will be approved for head and neck cancer patients, despite a delay in filing a new drug application for that indication.

    FORBES: Magazine Article

  • Similarly, a drug developer could be awarded a transferable right of priority (rapid) FDA review for a new drug application as an incentive for developing a new product to treat a rare disease.

    FORBES: Magazine Article

  • Bayer and Onyx will prepare a new drug application in the United States based on the information, but the trial will continue to see if their pill, code-named BAY 43-9006, extends patients' lives.

    FORBES: Two Wins For Biotech

  • Late last year, it submitted a new drug application to the FDA, hoping to market Lyrica as a treatment for fibromyalgia, a chronic, widespread pain that Pfizer says afflicts tens of millions of people.

    FORBES: Pfizer's New Blockbuster Drug

  • Those numbers mirror the results ImClone boasted of in 2001, before the U.S. Food and Drug Administration rejected a new drug application on the grounds that the data were not sufficient to prove that Erbitux worked.

    FORBES: Puncturing The ImClone Hype

  • The two companies filed a New Drug Application on Jan. 9, 2009 and learned in November that the agency extended the review date of Horizant to Feb. 9 to perform a risk evaluation and mitigation plan for the drug.

    FORBES: FDA Concerns Shake XenoPort, DepoMed

  • Maybe CMS should automatically begin reviewing a device as soon as a new drug application has been submitted to the FDA. That could not only get devices to patients faster, but also allow for more debate on medical costs, earlier.

    FORBES: Magazine Article

  • The next day ImClone announced that the U.S. Food and Drug Administration had rejected its application for the approval of its Erbitux cancer drug, the one product in its pipeline, causing a steep decline in the share price.

    FORBES: Martha Trial: 'Everyone Is Telling The Same Story'

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定